Loading stock data…
Neogen Corporation develops (NEOG)
$9.10-0.48 (-5.01%)
After Hours$9.10+0.00 (+0.00%)· Last close Jun 29
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Neogen Corporation in the Healthcare sector is trading at $9.10 with a market capitalization of $2.1B. Wall Street consensus targets $12.00 (3 analysts), implying a +31.9% move over the next 12 months. The stock is currently 20% below its 52-week high of $11.43, remaining 11.0% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +31.9% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $211.20M↓ | $224.69M↑ | $209.19M↓ | $225.46M↑ | $221.00M |
| Gross Profit | $99.00M↓ | $106.68M↑ | $94.97M↑ | $92.86M↓ | $110.30M |
| Operating Income | -$3.30M↑ | -$5.38M↑ | -$16.09M↓ | -$13.25M↓ | $5.40M |
| Net Income | -$17.00M↓ | -$15.92M↓ | $36.34M↑ | -$612.20M↓ | -$10.90M |
Peer Comparison
JNJUNHPFE
Fundamentals
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.05B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-28.96%
Volume
Today's trading volume
2.57M
Recent News
Neogen Gains 101.1% in a Year: What's Driving the Rally?
NEOG has surged as Food Safety growth, product launches and 3M integration support higher fiscal 2026 revenue guidance despite cost pressures.
Is it Worth Retaining NEOG Stock in Your Portfolio for Now?
Neogen has surged over the past year as product launches and 3M Food Safety integration progress, but debt levels and competition remain key concerns.
1 High-Flying Stock to Consider Right Now and 2 That Underwhelm
“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.
3 Unprofitable Stocks with Questionable Fundamentals
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.
How Investors Are Reacting To Neogen (NEOG) Petrifilm Shift and Operational Efficiency Push
Recently, Neogen reported solid core growth in its Food Safety segment while supplier issues weighed on its Animal Safety business, and management reiterated its focus on commercial execution, innovation, and operational efficiency. A key element was Neogen’s timeline to complete the transition of Petrifilm manufacturing by November 2026, which management believes should enhance margins and production control. We’ll now examine how Neogen’s progress on Petrifilm manufacturing and operational...